Chemical-structure.jpg (Image 1)
Austedo Xr Tablet, Film Coated, Extended Release
Product Images NDC 68546-470
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Austedo Xr (NDC 68546-470). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Neuroscience, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Image 10)
Hd 4-week Kit (Image 11)
Td 4-week Kit (Image 12)
Figure-01.jpg (Image 2)
This is a graph depicting the mean total maximal chorea score during a dose titration study of AUSTEDO compared to a placebo washout. AUSTEDO was administered to 45 patients while the same number were given a placebo. The study lasted for 13 weeks and the AUSTEDO group demonstrated a statistically significant improvement in chorea score compared to the placebo group.*
Figure-02.jpg (Image 3)
Figure-03.jpg (Image 4)
Figure-04.jpg (Image 5)
Image (Image 6)
Image (Image 7)
Product name: Austedo
Active ingredient: Deutetrabenazine
Strength: 9mg
Dosage form: Tablet
This text appears to be incomplete and does not provide a complete description of the product.*
Image (Image 8)
Image (Image 9)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
